Global Transient Ischemic Attack Market by Diagnosis (CT Scan, Magnetic Resonance Imaging, Others), Treatment, End User, Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025
Published On: March 2019
 
Report ID:375994
 
Category: Medical Devices
 
Pages: N/A




Global transient ischemic attack market is expected to reach USD 2467.82 Million by 2025, at a CAGR of 6.16% from 2018 to 2025. The rising prevalence of neurological disorders, increasing investments on biotechnology and pharmaceutical research activities, and the rising need for enhanced treatment methods are the factors that are driving the growth of the market.

Market Overview:

Transient ischemic attack (TIA) is also known as a "mini-stroke." It is caused by a temporary disruption in the blood supply to part of the brain. The disruption in blood supply results in a lack of oxygen to the brain. This can cause sudden symptoms similar to a stroke, such as speech and visual disturbance, and numbness or weakness in the face, arms, and legs. About 1 in 3 people who have a transient ischemic attack will eventually have a stroke, with about half occurring within a year after the transient ischemic attack. According to the American Heart Association and American Stroke Association guidelines, patients that experience Transient Ischemic Attack (TIA) should undergo head imaging within 24 hours of symptom onset, preferably with magnetic resonance imaging, including diffusion sequences. MRI is a better imaging modality for the diagnosis of TIA than Computed Tomography (CT).

Report Description:

  • The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global transient ischemic attack market is analyzed by value (USD Million)
  • The study delivers a comprehensive analysis of global transient ischemic attack market by diagnosis, treatment end user and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used to recognize the competitive scenario in the global transient ischemic attack market. This report incorporates the industry analysis which is focused on providing an extensive view of the transient ischemic attack market.
  • The study also includes attractiveness analysis of diagnosis, treatment end, user and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the transient ischemic attack market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • The rising prevalence of neurological disorders
  • Growing geriatric population

Restrains:

  • The paucity of skilled physicians and surgeons

Opportunities:

  • The growing preference for the wire-assisted surgery
  • Advancements in catheter devices technology

Challenges:

  • Rising treatment and hospitalization cost

Global Transient Ischemic Attack Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global transient ischemic attack market has been segmented by diagnosis, treatment end user and regions.

  • Diagnosis segment is divided into computed tomography (CT) scan, carotid duplex scanning, magnetic resonance Imaging, and echocardiography. Magnetic resonance imaging (MRI) segment led the global transient ischemic attack market with a 56.29% share of revenue in 2017. This increased market share can be attributed to better suitability and better imaging quality of the magnetic resonance imaging (MRI) technique.
  • Treatment is segmented into drugs and surgery. Drugs segment emerged as the leader with a 62.78% share of revenue in 2017. Drugs are the first line of treatment for curing transient ischemic attacks. Surgery segment is also anticipated to grow at a robust period owing to high procedure efficiency of minimally invasive surgeries coupled with their benefits such as faster recovery and less post-surgical pain.
  • The end-user segment is categorized into hospitals and clinics, diagnostic centers and research laboratories. Diagnostic centers and research laboratories segment and emerged as the largest with a 42.86% share of market revenue in 2017. Accurate and timely diagnosis is the most vital step for deciding the most effective line of treatment. Hospitals and clinics segment is anticipated to progress at an accelerated CAGR of 8.78% over the forecast period. An increasing number of private hospitals and clinics are anticipated to boost this increase in growth.    

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region held the largest share of global transient ischemic attack market with a 38.40% share of market revenue in 2017, followed by Europe.

  • Factors such as rising prevalence of neurological disorders, high per capita healthcare expenditure, and increasing government support for research and development activities as well as the presence of major pharmaceutical companies led North America to emerge as the dominant region in the global transient ischemic attack market.
  • Improvement in healthcare facilities and rise in awareness pertaining to personal health are the factors that are anticipated to drive Asia Pacific region to grow at an increased CAGR of 8.62% over the forecasted period.

Global Transient Ischemic Attack Market Competitive Analysis:

Key players in the global transient ischemic attack market are Koninklijke Philips N.V., Stryker Corporation, Johnson & Johnson Services Inc., Boston Scientific Corporation, Sanofi SA, Bayer AG, Pfizer Inc., Siemens AG, F. Hoffmann-La Roche AG, GE Healthcare, Penumbra, Inc., Medtronic PLC, Abbott Laboratories, Merck & Co., Inc., Boehringer Ingelheim GmbH, LivaNova PLC, Cyberonics, Inc, NeuroMetrix, Inc. among others. There is a worldwide increase in the prevalence of the neurological diseases. Thus to combat and prevent the onset transient ischemic attack, major firms are increasingly launching the newer treatment devices. For instance, Abbott Laboratories, in 2018 announced the trial results of its AMPLATZER™ Amulet™. It is a left atrial appendage (LAA) occlusion device that is used for treating the patients with irregular heartbeats. According to Abbott Laboratory’s claim, the AMPLATZER™ Amulet™ considerably reduces the risk of stroke, transient ischemic attack.

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global transient ischemic attack market by below-mentioned segments:

Global Transient Ischemic Attack Market by Diagnosis:

  • Computed Tomography (CT) Scan
  • Carotid Duplex Scanning
  • Magnetic Resonance Imaging
  • Echocardiography

Global Transient Ischemic Attack Market by Treatment:

  • Drugs
  • Surgery

Global Transient Ischemic Attack Market by End User:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Research Laboratories

Global Transient Ischemic Attack Market by Region:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market attractiveness analysis by Diagnosis
        4.3.2. Market attractiveness analysis by Treatment
        4.3.3. Market attractiveness analysis by End User
        4.3.4. Market attractiveness analysis by Region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. Rising prevalence of neurological disorders
        5.2.2. Growing geriatric population
   5.3. Restraints
        5.3.1. Paucity of skilled physicians and surgeons
   5.4. Opportunities
        5.4.1. Growing preference for the wire assisted surgery
        5.4.2. Advancements in catheter devices technology
   5.5. Challenges
        5.5.1. Rising treatment and hospitalization cost

6. Global Transient Ischemic Attack Market Analysis and Forecast, By Diagnosis
   6.1. Segment Overview
   6.2. Computed Tomography (CT) Scan
   6.3. Carotid Duplex Scanning
   6.4. Magnetic Resonance Imaging
   6.5. Echocardiography

7. Global Transient Ischemic Attack Market Analysis and Forecast, By Treatment
   7.1. Segment Overview
   7.2. Drugs
   7.3. Surgery

8. Global Transient Ischemic Attack Market Analysis and Forecast, By End User
   8.1. Segment Overview
   8.2. Hospitals & Clinics
   8.3. Diagnostic Centers
   8.4. Research Laboratories

9. Global Transient Ischemic Attack Market Analysis and Forecast, By Regional Analysis
   9.1. Segment Overview
   9.2. North America
        9.2.1. U.S.
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Europe
        9.3.1. Germany
        9.3.2. France
        9.3.3. Sweden
        9.3.4. Netherlands
        9.3.5. U.K.
        9.3.6. Italy
        9.3.7. Spain
        9.3.8. Turkey
        9.3.9. Switzerland
        9.3.10. Belgium
        9.3.11. Rest of Europe
   9.4. Asia-Pacific
        9.4.1. Japan
        9.4.2. China
        9.4.3. India
        9.4.4. South Korea
        9.4.5. Australia
        9.4.6. Singapore
        9.4.7. Malaysia
        9.4.8. Thailand
        9.4.9. Indonesia
        9.4.10. Philippines
        9.4.11. Rest of Asia-Pacific
   9.5. South America
        9.5.1. Brazil
        9.5.2. Argentina
        9.5.3. Colombia
        9.5.4. Rest of South America
   9.6. Middle East and Africa
        9.6.1. Saudi Arabia
        9.6.2. UAE
        9.6.3. Egypt
        9.6.4. Nigeria
        9.6.5. South Africa
        9.6.6. Rest of  Middle East and Africa

10. Global Transient Ischemic Attack Market-Competitive Landscape
   10.1. Overview
   10.2. Market Share of Key Players in the Transient Ischemic Attack Market
        10.2.1. Global Company Market Share
        10.2.2. North America Company Market Share
        10.2.3. Europe Company Market Share
        10.2.4. APAC Company Market Share
   10.3. Competitive Situations and Trends
        10.3.1. Treatment Launches and Developments
        10.3.2. Partnerships, Collaborations, and Agreements
        10.3.3. Mergers & Acquisitions
        10.3.4. Expansions

11. Company Profiles
   11.1. Koninklijke Philips N.V.
        11.1.1. Business Overview
        11.1.2. Company Snapshot
        11.1.3. Company Market Share Analysis
        11.1.4. Company Treatment Portfolio
        11.1.5. Recent Developments
        11.1.6. SWOT Analysis
   11.2. Stryker Corporation
        11.2.1. Business Overview
        11.2.2. Company Snapshot
        11.2.3. Company Market Share Analysis
        11.2.4. Company Treatment Portfolio
        11.2.5. Recent Developments
        11.2.6. SWOT Analysis
   11.3. Johnson & Johnson Services Inc
        11.3.1. Business Overview
        11.3.2. Company Snapshot
        11.3.3. Company Market Share Analysis
        11.3.4. Company Treatment Portfolio
        11.3.5. Recent Developments
        11.3.6. SWOT Analysis
   11.4. Boston Scientific Corporation
        11.4.1. Business Overview
        11.4.2. Company Snapshot
        11.4.3. Company Market Share Analysis
        11.4.4. Company Treatment Portfolio
        11.4.5. Recent Developments
        11.4.6. SWOT Analysis
   11.5. Sanofi SA
        11.5.1. Business Overview
        11.5.2. Company Snapshot
        11.5.3. Company Market Share Analysis
        11.5.4. Company Treatment Portfolio
        11.5.5. Recent Developments
        11.5.6. SWOT Analysis
   11.6. Bayer AG
        11.6.1. Business Overview
        11.6.2. Company Snapshot
        11.6.3. Company Market Share Analysis
        11.6.4. Company Treatment Portfolio
        11.6.5. Recent Developments
        11.6.6. SWOT Analysis
   11.7. Pfizer Inc
        11.7.1. Business Overview
        11.7.2. Company Snapshot
        11.7.3. Company Market Share Analysis
        11.7.4. Company Treatment Portfolio
        11.7.5. Recent Developments
        11.7.6. SWOT Analysis
   11.8. Siemens AG
        11.8.1. Business Overview
        11.8.2. Company Snapshot
        11.8.3. Company Market Share Analysis
        11.8.4. Company Treatment Portfolio
        11.8.5. Recent Developments
        11.8.6. SWOT Analysis
   11.9. Hoffmann-La Roche AG
        11.9.1. Business Overview
        11.9.2. Company Snapshot
        11.9.3. Company Market Share Analysis
        11.9.4. Company Treatment Portfolio
        11.9.5. Recent Developments
        11.9.6. SWOT Analysis
   11.10. GE Healthcare
        11.10.1. Business Overview
        11.10.2. Company Snapshot
        11.10.3. Company Market Share Analysis
        11.10.4. Company Treatment Portfolio
        11.10.5. Recent Developments
        11.10.6. SWOT Analysis
   11.11. Penumbra, Inc
        11.11.1. Business Overview
        11.11.2. Company Snapshot
        11.11.3. Company Market Share Analysis
        11.11.4. Company Treatment Portfolio
        11.11.5. Recent Developments
        11.11.6. SWOT Analysis
   11.12. Medtronic PLC
        11.12.1. Business Overview
        11.12.2. Company Snapshot
        11.12.3. Company Market Share Analysis
        11.12.4. Company Treatment Portfolio
        11.12.5. Recent Developments
        11.12.6. SWOT Analysis
   11.13. Abbott Laboratories
        11.13.1. Business Overview
        11.13.2. Company Snapshot
        11.13.3. Company Market Share Analysis
        11.13.4. Company Treatment Portfolio
        11.13.5. Recent Developments
        11.13.6. SWOT Analysis
   11.14. Merck & Co., Inc
        11.14.1. Business Overview
        11.14.2. Company Snapshot
        11.14.3. Company Market Share Analysis
        11.14.4. Company Treatment Portfolio
        11.14.5. Recent Developments
        11.14.6. SWOT Analysis
   11.15. Boehringer Ingelheim GmbH
        11.15.1. Business Overview
        11.15.2. Company Snapshot
        11.15.3. Company Market Share Analysis
        11.15.4. Company Treatment Portfolio
        11.15.5. Recent Developments
        11.15.6. SWOT Analysis


List of Table
1. Global Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
2. Global Computed Tomography (CT) Scan Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million) 
3. Global Carotid Duplex Scanning Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million)
4. Global Magnetic Resonance Imaging Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million)
5. Global Echocardiography Transient Ischemic Attack Market, By Region, 2015–2025  (USD Million)
6. Global Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
7. Global Drugs Transient Ischemic Attack Market, BY Region, 2015–2025 (USD Million) 
8. Global Surgery Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million)  
9. Global Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
10. Global Hospitals & Clinics Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million) 
11. Global Diagnostic Centers Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million) 
12. Global Research Laboratories Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million) 
13. Global Transient Ischemic Attack Market, By Region, 2015–2025 (USD Million) 
14. Global Transient Ischemic Attack Market, By North America, 2015–2025 (USD Million) 
15. North America Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
16. North America Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
17. North America Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
18. U.S. Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
19. U.S. Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
20. U.S. Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
21. Canada Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
22. Canada Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
23. Canada Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
24. Mexico Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
25. Mexico Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
26. Mexico Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
27. Europe Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
28. Europe Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
29. Europe Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
30. Germany Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
31. Germany Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
32. Germany Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
33. France Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
34. France Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
35. France Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
36. Sweden Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
37. Sweden Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
38. Sweden Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
39. Netherlands Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
40. Netherlands Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
41. Netherlands Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
42. U.K. Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
43. U.K. Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
44. U.K. Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
45. Italy Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
46. Italy Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
47. Italy Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
48. Spain Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
49. Spain Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
50. Spain Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
51. Turkey Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
52. Turkey Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
53. Turkey Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
54. Switzerland Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
55. Switzerland Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
56. Switzerland Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
57. Belgium Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
58. Belgium Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
59. Belgium Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
60. Asia Pacific Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
61. Asia Pacific Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
62. Asia Pacific Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
63. Japan Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
64. Japan Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
65. Japan Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
66. China Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
67. China Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
68. China Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
69. India Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
70. India Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
71. India Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
72. South Korea Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
73. South Korea Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
74. South Korea Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
75. Australia Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
76. Australia Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
77. Australia Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
78. Singapore Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
79. Singapore Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
80. Singapore Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
81. Malaysia Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
82. Malaysia Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
83. Malaysia Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
84. Thailand Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
85. Thailand Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
86. Thailand Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
87. Indonesia Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
88. Indonesia Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
89. Indonesia Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
90. Philippines Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
91. Philippines Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
92. Philippines Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
93. South America Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
94. South America Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
95. South America Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
96. Brazil Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
97. Brazil Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
98. Brazil Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
99. Argentina Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
100. Argentina Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
101. Argentina Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
102. Colombia Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
103. Colombia Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
104. Colombia Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
105. Middle East and Africa Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
106. Middle East and Africa Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
107. Middle East and Africa Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
108. Saudi Arabia Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
109. Saudi Arabia Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
110. Saudi Arabia Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
111. UAE Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
112. UAE Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
113. UAE Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
114. Egypt Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
115. Egypt Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
116. Egypt Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
117. Nigeria Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
118. Nigeria Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
119. Nigeria Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 
120. South Africa Transient Ischemic Attack Market, By Diagnosis, 2015–2025 (USD Million) 
121. South Africa Transient Ischemic Attack Market, By Treatment, 2015–2025 (USD Million) 
122. South Africa Transient Ischemic Attack Market, By End User, 2015–2025 (USD Million) 

List of Figures 
1. Global Transient Ischemic Attack Market Segmentation
2. Collagen Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis 
7. Value Chain Analysis 
8. Global Transient Ischemic Attack Market attractiveness analysis by Diagnosis
9. Global Transient Ischemic Attack Market attractiveness analysis by Treatment
10. Global Transient Ischemic Attack Market attractiveness analysis by End User
11. Global Transient Ischemic Attack Market attractiveness analysis by Region
12. Global Transient Ischemic Attack Market: Dynamics
13. Global Transient Ischemic Attack Market Share by Diagnosis (2017 & 2025)
14. Global Transient Ischemic Attack Market Share by Treatments (2017 & 2025)
15. Global Transient Ischemic Attack Market Share by End User (2017 & 2025)
16. Global Transient Ischemic Attack Market Share by Regions (2017 & 2025)
17. Global Transient Ischemic Attack Market Share by Company (2018)



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.